Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04998487 · ClinicalTrials.gov registry record · Phase 1

A Single-Dose Study of LY3471851 in Healthy Participants

A Phase 1 study of Healthy, sponsored by Nektar Therapeutics.

Completed
Registry status
Phase 1
Development phase
71
Enrollment target
1
Study location

NCT04998487: Completed Phase 1 study of Healthy, sponsored by Nektar Therapeutics.

NCT04998487 is a Phase 1 study of Healthy that has completed, run by Nektar Therapeutics. The registered enrollment target is 71 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04998487, a Phase 1 study of Healthy, has completed, sponsored by Nektar Therapeutics.

COMPLETED
Registry status
Phase 1
Development phase
71 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this study is to estimate how much LY3471851 gets into the blood stream and how long it takes the body to remove it when administered under the skin in healthy participants. The study will also evaluate the safety and tolerability of LY3471851. The study is expected to last up to 87 days for each participant.

Conditions Studied

Healthy

Interventions

  • DRUG LY3471851

Study Locations (1)

Florida

  • LabCorp CRU, Inc. - Daytona Beach

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2021-08-16
Est. Completion 2022-07-06
Phase Phase 1

Sponsor

Nektar Therapeutics

37 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04998487

The ClinicalTrials.gov registry entry for NCT04998487 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The listed sponsor is Nektar Therapeutics, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which LY3471851 is the first listed.

NCT04998487 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04998487 about?

NCT04998487 is a clinical study titled "A Single-Dose Study of LY3471851 in Healthy Participants". The main purpose of this study is to estimate how much LY3471851 gets into the blood stream and how long it takes the body to remove it when administered under the skin in healthy participants. The study will also evaluate the safety and tolerability of LY3471851. The study is expected to last up to...

What is the current status of trial NCT04998487?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 71 participants. The study started on 2021-08-16. Estimated completion is 2022-07-06.

What conditions does trial NCT04998487 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT04998487?

The interventions under investigation include: LY3471851 (DRUG).

Who is sponsoring clinical trial NCT04998487?

This trial is sponsored by Nektar Therapeutics, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04998487 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.